Simply Wall St.
Assessing Spyre Therapeutics (SYRE) Valuation After Strong One Year Return And Premium Price To Book Ratio
➖
AI Sentiment
Neutral
4/10
Spyre Therapeutics Inc. News
Latest updates and market news for SYRE
2 news
Mar 18 - Mar 24, 2026
Page 1
Motley Fool
Signal or Noise: What VR Adviser's Spyre Theraputics Buy Means for Fools
📈
AI Sentiment
Highly Positive
9/10
Share this news page